EFFPHA, EFFICIENT PHARMA MANAGEMENT CORP. - Trademark Details
Status: 800 - Registered And Renewed
Image for trademark with serial number 85031356
Serial Number
85031356
Registration Number
3896949
Word Mark
EFFPHA, EFFICIENT PHARMA MANAGEMENT CORP.
Status
800 - Registered And Renewed
Status Date
2020-06-09
Filing Date
2010-05-06
Registration Number
3896949
Registration Date
2010-12-28
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260912, 260928 - Squares with bars, bands and lines. Miscellaneous designs with overall square shape.
Published for Opposition Date
2010-10-12
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
HOFFMAN, DAVID AARON
Statements
Indication of Colors claimed
The color(s) blue, orange, green, gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMA MANAGEMENT CORP."
Description of Mark
The mark consists of square design to the left of the wording "EffPha" in blue. The color blue also appears in the upper right corner portion of a square design and has a vertical gradient going from a darker blue to a milder blue, then to a light blue. The color orange appears in the leftmost vertical stripe of the square design. The color green appears in the lower right portion of the square design. A circular figure is cut out of the center of the square design, which is transparent in color. Two vertical parallel lines cut through the square design, also transparent in color. The wording "Efficient Pharma Management Corp." appears below the square design and the wording "EffPha", in gray. The color white merely indicates background and is not part of the mark.
Goods and Services
Bacteriological consultation and research; Biochemical research and development; Biological research; Chemical analysis; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Chemistry consultation; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting early evaluations in the field of new pharmaceuticals; Consultancy pertaining to pharmacology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Cosmetic research consultation; Cosmetics research; Cosmetics research for others; Development of pharmaceutical preparations and medicines; Drug discovery services; Information on the subject of scientific research in the field of biochemistry and biotechnology; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Product development; Product development consultation; Product development for others; Product research; Product research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development for new products for others; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research in the field of chemistry; Research on the subject of pharmaceuticals; Scientific research and development
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2010-05-11
Primary Code
042
First Use Anywhere Date
2009-10-15
First Use In Commerce Date
2009-10-15
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Alan D. Kamrath
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2010-05-10NEW APPLICATION ENTERED IN TRAM
2010-05-11NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2010-05-12NOTICE OF DESIGN SEARCH CODE MAILED
2010-08-18ASSIGNED TO EXAMINER
2010-08-24EXAMINERS AMENDMENT -WRITTEN
2010-08-24EXAMINERS AMENDMENT E-MAILED
2010-08-24NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2010-08-24EXAMINER'S AMENDMENT ENTERED
2010-08-24APPROVED FOR PUB - PRINCIPAL REGISTER
2010-09-07ASSIGNED TO LIE
2010-09-07LAW OFFICE PUBLICATION REVIEW COMPLETED
2010-10-12PUBLISHED FOR OPPOSITION
2010-10-12OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2010-12-28REGISTERED-PRINCIPAL REGISTER
2015-12-28COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2016-04-08TEAS CHANGE OF CORRESPONDENCE RECEIVED
2016-04-08TEAS SECTION 8 & 15 RECEIVED
2016-06-15CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2016-06-15REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
2016-06-15NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
2019-12-28COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
2020-03-25TEAS SECTION 8 & 9 RECEIVED
2020-06-09CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2020-06-09REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
2020-06-09REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
2020-06-09NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED